Patients with multiple conditions of inflammatory bowel disease (IBD) are among the biggest challenges facing IBD specialists. At the 2019 Crohn’s & Colitis Congress®, closing session, Management of Complicated IBD, moderators Judy Cho, MD, of Mount Sinai, and Alessandro Fichera, MD, of the University of North Carolina, will lead faculty in providing the latest research and case-specific examples of the most challenging complications.
“The closing session of the congress will address ‘how do you take care of patients who have multiple extra intestinal manifestations or complex perianal disease or who have required multiple surgeries, the really tough cases,’ ” said David Rubin, MD, AGAF, of the University of Chicago and co-chair of the congress’ Organizing Committee.
Among the areas of focus for the Management of Complicated IBD session will be:
-
- Complications of IBD: Does Anti-TNF Prevent Stricturing Complications?
-
- Mechanisms of Stricturing IBD.
-
- What Are We Doing for Anti-TNF Refractory Patients?
The session also offers attendees the option to attend one of three breakout sessions:
-
- Stricturing Disease
-
- Perianal Disease
-
- Modern Management of Dysplasia
The Crohn’s & Colitis Congress, a partnership of the Crohn’s & Colitis Foundation and AGA, provides a multidisciplinary perspective on treating IBD for health care professionals and researchers. The congress will be held Feb. 7–9, 2019, in Las Vegas. Discounted registration rates apply through Dec. 12.
